GlassScriptPhysician profile
Catherine C Murphy
NPI 1346448495
$5,674.25
in general payments reported to CMS, 2019-2025
28 companies · $1,225 in 2025
The $1,225 reported for 2025 was more than what 90% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $518 · 2022: $1,922 · 2023: $826 · 2024: $1,183 · 2025: $1,225.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,234.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,233.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,196.16 | 2021-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $743.08 | 2021-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $584.19 | 2021-2024 | Farxiga, Lokelma |
| Boehringer Ingelheim Pharmaceuticals, INC. | $535.04 | 2022-2025 | Jardiance |
| Amgen INC. | $382.94 | 2022-2025 | Repatha, Repatha |
| Boston Scientific Corporation | $277.53 | 2023-2025 | Watchman Flx, Watchman |
| Merck Sharp & Dohme LLC | $223.53 | 2022-2025 | Verquvo, Capvaxive |
| Novartis Pharmaceuticals Corporation | $214.38 | 2021-2025 | |
| Alnylam Pharmaceuticals INC. | $210.88 | 2022-2024 | Onpattro |
| Pfizer INC. | $191.77 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $185.01 | 2024-2025 | |
| Edwards Lifesciences Corporation | $168.78 | 2022-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Abbvie INC. | $131.82 | 2024 | |
| Sanofi-Aventis U.S. LLC | $104.18 | 2022-2023 | |
| Baxter Healthcare | $86.73 | 2023 | Hillrom - Carnation Ambulatory Monitor |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $60.51 | 2021-2025 | Thoratec Heartmate 3 Lvas Implant Kit |
| E.R. Squibb & Sons, L.L.C. | $54.75 | 2022-2025 | Eliquis, Camzyos |
| Kestra Medical Technology Services, INC. | $45.41 | 2025 | Assure Wcd |
| Kiniksa Pharmaceuticals International, Plc | $43.56 | 2024 | Arcalyst |
| Impulse Dynamics (USA) INC. | $40.41 | 2023-2024 | Optimizer, Optimizer |
| Abiomed | $38.67 | 2024-2025 | Impella |
| Novo Nordisk INC | $35.10 | 2025 | Wegovy |
| Bridgebio Pharma, INC. | $27.63 | 2025 | Attruby |
| Cardiva Medical, INC. | $23.73 | 2021 | |
| Lilly USA, LLC | $19.94 | 2023 | Mounjaro |
| Dexcom, INC. | $18.17 | 2024 | Dexcom G6 Transmitter |
| Actelion Pharmaceuticals US, INC. | $16.84 | 2024 | Opsumit, Uptravi |
| Esperion Therapeutics, INC. | $13.51 | 2025 | Nexletol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catherine Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.